| Target Validation Information | |||||
|---|---|---|---|---|---|
| Target ID | T50970 | ||||
| Target Name | Endothelin-converting enzyme 1 | ||||
| Target Type | Discontinued |
||||
| Drug Potency against Target | PO3 2-Leu-Trp-O-3K | Drug Info | IC50 = 960 nM | ||
| LY-292223 | Drug Info | IC50 = 67 nM | [527383] | ||
| PO3 2-Leu-Nal-O-3K | Drug Info | IC50 = 7400 nM | |||
| PO3 2-Nle-Trp-O-3K | Drug Info | IC50 = 1500 nM | |||
| PO3 2-Ile-Trp-O-3K | Drug Info | IC50 = 2800 nM | |||
| SCH-54470 | Drug Info | IC50 = 80 nM | [530505] | ||
| References | |||||
| Ref 527383 | J Med Chem. 2005 Jan 27;48(2):483-98.Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells. | ||||
| Ref 530505 | J Med Chem. 2010 Jan 14;53(1):208-20.Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.